Joseph F Merola

Joseph F Merola

Harvard University - Cambridge / United States
Others
AD Scientific Index ID: 4512611
person_outline Joseph F Merola's MOST POPULAR ARTICLES
1-) Two phase 3 trials of dupilumab versus placebo in atopic dermatitisEL Simpson, T Bieber, E Guttman-Yassky, LA Beck, A Blauvelt, MJ Cork, ...New England Journal of Medicine 375 (24), 2335-2348, 201617892016
2-) 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritisJA Singh, G Guyatt, A Ogdie, DD Gladman, C Deal, A Deodhar, ...Journal of Psoriasis and Psoriatic arthritis 4 (1), 31-58, 20197312019
3-) Tofacitinib or adalimumab versus placebo for psoriatic arthritisP Mease, S Hall, O FitzGerald, D van der Heijde, JF Merola, ...New England Journal of Medicine 377 (16), 1537-1550, 20175332017
4-) Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transitionJU Scher, A Ogdie, JF Merola, C RitchlinNature Reviews Rheumatology 15 (3), 153-166, 20193162019
5-) Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active …K Reich, KA Papp, A Blauvelt, RG Langley, A Armstrong, RB Warren, ...The Lancet 397 (10273), 487-498, 20212562021